Innovaccer is deploying its web-based HIPAA-compliant COVID-19 Management System across hundreds of primary care practices, government agencies and healthcare systems at no cost. Capabilities include:

This slide deck is from Dr. Scott Conard, who leads a practice in Texas, and who wished to educate his patients about COVID-19.  He  set out to do so via a group telehealth visit.  This deck could be adapted by other primary care leaders with appropriate credit.  Contact Dr. Conard at scott@scottconard.com   

Overview
This presentation offers learners an overview of how to use telemental health and video visits in the changing landscape surrounding the 2020 COVID-19 pandemic. As clinicians seek to quickly offer remote and video visits, it is important that they be aware of the legal, clinical, cultural, and practical aspects in using technology to deliver care. This presentation covers topics including assessing which telemental health platform to use, licensure, issues around consent, online prescribing, billing and payments, and special situations.

PCC Executive Members and related organizations may use this text to help promote the weekly survey that PCC is conducting in partnership with the Larry A. Green Center on clinicians' response to the COVID-19 crisis.

This text has been generated to help these organizations inform their own members and networks of the survey and encourage those individuals to take the survey.

Geisinger Health Plan developed a chatbot to help triage and screen patients remotely. In addition, it’s setting up video chat capabilities for admitted patients allowing them to contact their families at home.

Geisinger Health Plan serves more than 3 million patients in 45 counties in Pennsylvania and southern New Jersey. Geisinger’s CIO, John Kravitz, said his team was moving at “lightning speed” to keep things moving. “We’ve never experienced anything like this,” Kravitz told the publication. “You get things done, you plan on the fly.” 

UPMC developed a new COVID-19 test, filling a critical gap before other commercial tests were available. UPMC will use this test to diagnose select, symptomatic cases. The health system plans to rapidly increase capacity at its central laboratory and, if there is a need, could test hundreds of patients per week in the near future.